What are hepatitis B surface antibody (anti‑HBs), hepatitis B core antibody IgM (anti‑HBc IgM), and hepatitis B core antibody IgG (anti‑HBc IgG)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Understanding Hepatitis B Serological Markers

Anti-HBs (Hepatitis B Surface Antibody)

Anti-HBs is the antibody that develops after either successful hepatitis B vaccination or recovery from natural HBV infection, and it provides protective immunity against future hepatitis B infection. 1

  • Anti-HBs appears after clearance of HBsAg (hepatitis B surface antigen) in natural infection and is the sole marker present after vaccination, indicating protective immunity 2
  • A level of ≥10 mIU/mL is considered protective and confirms immunity 1, 2
  • When anti-HBs is the only positive marker, this confirms immunity from vaccination alone without prior natural infection 1
  • When anti-HBs is positive alongside anti-HBc (and HBsAg negative), this indicates recovery from past natural infection with resulting immunity 1, 2

Anti-HBc IgM (Hepatitis B Core Antibody IgM)

Anti-HBc IgM is the definitive marker for acute or recently acquired hepatitis B infection, appearing at symptom onset and typically persisting for up to 6 months after infection. 3

  • IgM anti-HBc is the most reliable marker for distinguishing acute from chronic HBV infection 3
  • It appears at the onset of symptoms or liver test abnormalities in acute HBV infection 3
  • A strong positive IgM anti-HBc during acute hepatitis is indicative of acute HBV infection even in HBsAg-negative patients 4
  • Testing should be limited to persons with clinical evidence of acute hepatitis or epidemiologic link to HBV infection due to low positive predictive value in asymptomatic persons 3

Important Clinical Caveat

  • In patients with chronic HBV infection, IgM anti-HBc can persist at low levels during viral replication or during exacerbations, potentially leading to misdiagnosis as acute infection 3, 4
  • Weak positive results in HBsAg-positive patients without recent acute hepatitis cannot always be regarded as definite markers of recent infection 4

Anti-HBc IgG (Total Anti-HBc)

Total anti-HBc (which includes both IgM and IgG) appears at symptom onset and persists for life in most infected persons, serving as a permanent marker of HBV exposure—past or present. 2

  • Total anti-HBc remains detectable for life after hepatitis B infection 2
  • Anti-HBc is never generated by vaccination; its presence always signifies natural infection (past or present) 2
  • This marker is the key differentiator between natural immunity (anti-HBc positive + anti-HBs positive) and vaccine-induced immunity (anti-HBc negative + anti-HBs positive) 1, 2

Clinical Interpretation Algorithm

For determining immune status:

  1. First-line testing: Measure HBsAg and anti-HBs simultaneously to identify current infection and immunity 1
  2. If anti-HBs is positive: Add total anti-HBc to distinguish natural immunity (anti-HBc positive) from vaccine-induced immunity (anti-HBc negative) 1

For diagnosing acute vs. chronic infection:

  • Acute infection: HBsAg positive + IgM anti-HBc positive + Anti-HBs negative 3
  • Chronic infection: HBsAg positive + IgM anti-HBc negative (but total anti-HBc positive) + Anti-HBs negative 3
  • Resolved infection: HBsAg negative + Anti-HBs positive + Total anti-HBc positive 2, 3
  • Vaccine immunity only: HBsAg negative + Anti-HBs positive + Anti-HBc negative 2

Special consideration for isolated anti-HBc positivity:

  • Resolved infection with waning anti-HBs is the most common explanation in high-prevalence populations 2
  • Consider HBV DNA testing to detect occult hepatitis B, especially in immunocompromised individuals or those from high-prevalence regions 2

References

Guideline

Interpretation of Negative Surface Antibody Qualitative Test for Hepatitis B

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hepatitis B Serology Interpretation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Acute Hepatitis B Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Which hepatitis test checks for immunity to Hepatitis (inflammation of the liver)?
What does a hepatitis B panel showing hepatitis B surface antigen positive, hepatitis B surface antibody <3.5 IU/L, hepatitis B e‑antigen negative and hepatitis B e‑antibody negative indicate and what are the recommended next steps?
What is the diagnosis for a patient presenting with fatigue, jaundice, and abdominal pain, with lab results showing positive Hepatitis B surface antigen (HBsAg), negative Hepatitis B surface antibody (anti-HBs), and positive Immunoglobulin M antibody to Hepatitis B core antigen (anti-HBc IgM)?
Can you interpret my hepatitis serology results: hepatitis A total antibody positive, hepatitis A IgM negative; hepatitis B surface antigen negative, surface antibody non‑reactive, core total antibody negative; hepatitis C antibody non‑reactive, and advise what to do next?
In hepatitis B infection, which is detected first, the Hepatitis B surface antigen (HBsAg) or the Immunoglobulin M (IgM) anti-core antibody?
What is the recommended starting dose, titration schedule, maximum dose, side effects, contraindications, and tapering plan for baclofen in an adult without significant renal impairment being treated for spasticity?
In an adult patient with bipolar disorder starting lithium therapy at therapeutic serum levels, does lithium cause weight gain?
What is the APACHE‑II scoring guide for ICU admission and early management of acute pancreatitis?
How should intermittent hematuria in a man taking bupropion be evaluated and managed?
How can weight gain be prevented in a patient on lithium therapy?
What is the recommended dosing regimen for intravenous piperacillin‑tazobactam (Zosyn) in adults and children, including adjustments for severe infections and impaired renal function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.